Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Scinvivo B.V. logo — Optical biopsy for bladder cancer diagnostics

Scinvivo B.V.

Optical biopsy for bladder cancer diagnostics

Founded 2016 The Netherlands The Netherlands 17 employees Venture round Total: $5.00M Biotechnology, Health Care +2

General Information

Company Name Scinvivo B.V.
Founded Year 2016
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member Team member Team member
Employees 17
Industries Biotechnology, Health Care, Information Technology +1
Funding Stage Venture round
Business Model B2B, SaaS, Platform
Social

BounceWatch is an independent company data service, not affiliated with Scinvivo B.V.. To contact Scinvivo B.V., visit scinvivo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Scinvivo B.V. compare?

A PDF of Scinvivo B.V. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Scinvivo B.V. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Scinvivo B.V.

Scinvivo B.V., founded in 2016 and headquartered in The Netherlands, is revolutionizing the diagnostics of bladder cancer with its proprietary technology. With the slogan "Optical biopsy for bladder cancer diagnostics", Scinvivo addresses significant limitations in current imaging technologies.

Existing techniques often misclassify healthy tissue as cancerous in 30% of cases, complicating the surgical removal of tumors and failing to gauge the invasion depth—an essential factor for treatment planning. The company's cutting-edge technology enhances diagnostic accuracy, reducing unnecessary interventions, patient burdens, and associated costs.

Positioned at the intersection of Biotechnology, Health Care, Information Technology, and Medical Devices, Scinvivo recently secured a €4.70M investment from NLC and Santec Corporation in a venture round on 21 February 2024, demonstrating strong investor confidence in its potential to transform bladder cancer diagnostics.

Business keywords: Optical Biopsy, Bladder Cancer Diagnostics, Medical Technology, Urological Imaging, Optical Coherence Tomography, Endoscopic Imaging, Cancer Diagnostics, Real-Time Imaging, Ultra High Resolution Imaging, Anatomical Structure Analysis, Minimally Invasive Diagnostics, Tumor Visualization, Invasion Depth Assessment

Services & Products

Realtime Imaging Platform
Non-invasive Cancer Diagnostics
High-resolution Tissue Visualization
AI-assisted Diagnosis

Target Customers

Medical Professionals Urologists Hospitals Healthcare Providers Cancer Research Institutions Bladder Cancer Patients

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Undisclosed 1
Netherlands Enterprise Agency
Netherlands Enterprise Agency
21 Feb 2024
Venture Round €4.70M 2
NLC, Santec Corporation
21 Feb 2024
Pre Seed Round $300.00K 1
Innovatiefonds Noord-Holland
Innovatiefonds Noord-Holland
28 Nov 2018
Pre Seed Round Undisclosed 1
NLC
16 Nov 2016

Scinvivo B.V. Alternatives & Competitors

View All Alternatives
Scinvivo B.V. vs
Exact Imaging
Exact Imaging Canada

Revolutionizing targeted prostate cancer biopsies

43 employees
Biotechnology, Health Care
Compare Scinvivo B.V. vs Exact Imaging
Scinvivo B.V. vs
Diagnostic Photonics
Diagnostic Photonics United States

Pioneering real-time tissue imaging for enhanced medical diagnostics, originating from a leading int...

Series B
1 employees
Biotechnology, Health Care
Scinvivo B.V. vs
iThera Medical
iThera Medical Germany

Biomarkers, in living color.

Series D
65 employees
Biotechnology, Health Care
Compare Scinvivo B.V. vs iThera Medical
View all alternatives

FAQ About Scinvivo B.V.

Optical biopsy for bladder cancer diagnostics
Scinvivo B.V. was founded in 2016.
Scinvivo B.V. is headquartered in The Netherlands.
Scinvivo B.V. operates in Biotechnology, Health Care, Information Technology and Medical Devices. Its work centres on Optical Biopsy, Bladder Cancer Diagnostics, Medical Technology and Urological Imaging. Its customers include Medical Professionals, Urologists and Hospitals.
Scinvivo B.V. has a B2B, SaaS and Platform business model.
Scinvivo B.V. has approximately 17 employees.
Scinvivo B.V. has completed 4 funding rounds, raising a total of $5.00M. The latest funding stage is Venture round.
Scinvivo B.V. offers: Realtime Imaging Platform, Non-invasive Cancer Diagnostics, High-resolution Tissue Visualization, AI-assisted Diagnosis.
Top alternatives and competitors to Scinvivo B.V. include Exact Imaging, Diagnostic Photonics, iThera Medical, Galil Medical Ltd., Oxford Cancer Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Scinvivo B.V. and Exact Imaging are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Scinvivo B.V., https://bouncewatch.com/company/scinvivo-bv, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout